Bristol Myers Squibb (BMY) Receivables (2009 - 2026)
Bristol Myers Squibb (BMY) reported Receivables of $10.72 billion for Q3 2026, down 18.9% from $13.22 billion a year earlier but up 0.6% from the prior quarter.
Bristol Myers Squibb (BMY) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb posted Receivables of $13.24 billion, up 6.0% from FY2024.
- Receivables has a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
- By year, Receivables came in at $12.48 billion in FY2024 (-3.7%), $12.96 billion in FY2023 (+11.5%), $11.62 billion in FY2022 (+8.0%) and $10.76 billion in FY2021 (+10.0%).
- Five-year quarterly Receivables spans a low of $9.73 billion in Q4 2021 and a high of $13.22 billion in Q3 2025.
- Year over year, Receivables has now declined in each of the last three quarters, with an average decline of 5.2% over the last eight quarters.
- The high point for year-over-year Receivables in five years was Q1 2023 (growth of 24.2%); the low point was Q3 2026 (a decline of 18.9%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $10.66 billion (Q2 2026), $10.79 billion (Q1 2026) and $11.61 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 10.72 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.72 Bn |
| Jun 30, 2026 | 10.66 Bn |
| Mar 31, 2026 | 10.79 Bn |
| Dec 31, 2025 | 11.61 Bn |
| Sep 30, 2025 | 13.22 Bn |
| Jun 30, 2025 | 13.12 Bn |
| Mar 31, 2025 | 12.54 Bn |
| Dec 31, 2024 | 11.13 Bn |
| Sep 30, 2024 | 12.74 Bn |
| Jun 30, 2024 | 13.10 Bn |
| Mar 31, 2024 | 12.07 Bn |
| Dec 31, 2023 | 11.34 Bn |
| Sep 30, 2023 | 12.20 Bn |
| Jun 30, 2023 | 12.10 Bn |
| Mar 31, 2023 | 12.25 Bn |
| Dec 31, 2022 | 10.39 Bn |
| Sep 30, 2022 | 11.21 Bn |
| Jun 30, 2022 | 10.52 Bn |
| Mar 31, 2022 | 9.87 Bn |
| Dec 31, 2021 | 9.73 Bn |
Bristol Myers Squibb Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();